Quarterly Results

SURYA PHARMACEUTICAL LTD.

NSE : SURYAPHARMBSE : 532516ISIN CODE : INE249G01020Industry : Pharmaceuticals & DrugsHouse : Private
BSE0.160 (0 %)
PREV CLOSE ( ) 0.16
OPEN PRICE ( ) 0.16
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.16 (749508)
VOLUME 234695
TODAY'S LOW / HIGH ( )0.16 0.16
52 WK LOW / HIGH ( )0.16 0.16
NSE1.400 (0 %)
PREV CLOSE( ) 1.40
OPEN PRICE ( ) 1.40
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1.40 (16282)
VOLUME 1133246
TODAY'S LOW / HIGH( ) 1.30 1.40
52 WK LOW / HIGH ( )0.1 0.2
Quarters
Select year  
( in Million)
Particulars
Dec 2014
Sep 2014
Jun 2014
Mar 2014
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
0.00
4.32
4.32
17.4
Total Expenditure
171.72
174.79
15.17
129.18
PBIDT (Excl OI)
-171.72
-170.47
-10.85
-111.78
Other Income
0.00
0.00
NA
4.42
Operating Profit
-171.72
-170.47
-10.85
-107.36
Interest
0.15
0.46
0.76
1077.75
Exceptional Items
0.11
0.00
NA
NA
PBDT
-171.76
-170.93
-11.61
-1185.11
Depreciation
NA
NA
156.14
156.22
Profit Before Tax
-171.76
-170.93
-167.75
-1341.33
Tax
0.00
0.00
NA
-4438.53
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
-171.76
-170.93
-167.75
3097.19
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
-171.76
-170.93
-167.75
3097.19
Equity Capital
202.76
202.75
202.75
202.75
Face Value (IN RS)
1
1
1
1
Reserves
0
0
Calculated EPS
-0.84
-0.84
-0.82
15.27
Calculated EPS (Annualised)
-3.38
-3.37
-3.30
61.10
No of Public Share Holdings
175051427
166937565
159713656
159713656
% of Public Share Holdings
86.34
82.34
78.77
78.77
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
NA
-3946.06
-251.15
-642.41
PBIDTM%
NA
-3946.06
-251.15
-617.01
PBDTM%
NA
-3956.71
-268.75
-6810.97
PBTM%
NA
-3956.71
-3883.10
-7708.79
PATM%
NA
-3956.71
-3883.10
17799.94
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)